Trial reportAnesthesiology2025
A Pharmacist-partnered Opioid-tapering Service before Total Hip or Knee Arthroplasty: Qualitative Analysis of Patient Counseling Sessions.
Trial report in Anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Patient perspectives and experiences of collaborative pharmacist prescribing in the hospital inpatient setting: a cross-sectional survey.International journal of clinical pharmacy · 2026Article
- Article
- Pharmacists may facilitate opioid tapering before total hip or knee arthroplasty.Annals of joint · 2026Article
Corrections and comments
- Commented on by
Authors and funding
28 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCurrently, no literature on patients' experiences with opioid tapering before elective surgery has been published. Recent evidence indicates that tapering opioids before total hip or knee arthroplasty improves postsurgical outcomes. This study qualitatively analyzed consultation sessions of patients receiving a pharmacist-partnered opioid-tapering service before total hip or knee replacement surgery to understand their experiences and attitudes.
methodsA qualitative analysis of pharmacist counseling sessions within a randomized controlled trial was conducted. Participants were those recruited from seven hospitals between December 2021 and September 2022 who were assigned to the pharmacist-partnered opioid-tapering intervention arm of a randomized controlled trial. Consultations of participants with the pharmacist were audio-recorded and transcribed verbatim. Consultation data underwent inductive thematic analysis.
resultsConsultations were available for 20 participants, with a total of 48 audio-recorded consultations. Among these participants, four major themes including motivations to taper, knowledge and beliefs, psychosocial context, and attitudes toward tapering opioids were identified. Of the 20 participants, 70% tapered their opioids 50% or greater, with awareness of the surgery date appearing to be a key external motivating factor to taper opioids, regardless of the dose of opioids. Another notable theme was the motivation to improve fitness for participation in social activities, allowing participants to interact more with their kids and grandkids. Additionally, participant's psychosocial context revealed that factors such as stress affected their ability to taper. Pharmacists played a foundational role in shaping patients' attitudes and optimization of pain management strategies. Attitudes were identified as "optimistic," "hesitant," and "resistant," with patients displaying an optimistic attitude being more likely to taper.
conclusionsExploring the experiences of patients with osteoarthritis in a pharmacist-led opioid-tapering service before elective surgery revealed that external motivations, such as knowledge of a surgery date, play a crucial role in successful opioid tapering. Patients were more likely to taper if they knew their surgery date. Attitudes toward opioid tapering were identified as a modifiable factor. Tailoring tapering plans and patient education to individual patient contexts may enhance tapering outcomes.
Indexed as
Identifiers
40478604What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.